Research output per year
Research output per year
Fingerprint
Dive into the research topics where Mark Weiser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
Weiser, M., Levi, L., Park, J., Nastas, I., Matei, V., Davidson, M., Arad, I., Dudkiewicz, I. & Davis, J. M., Aug 2023, In: European Neuropsychopharmacology. 73, p. 65-74 10 p.Research output: Contribution to journal › Article › peer-review
-
Association of Complement and Coagulation Pathway Proteins with Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial
Susai, S. R., Focking, M., Mongan, D., Heurich, M., Coutts, F., Egerton, A., Whetton, T., Winter-Van Rossum, I., Unwin, R. D., Pollak, T. A., Weiser, M., Leboyer, M., Rujescu, D., Byrne, J. F., Gifford, G. W., Dazzan, P., Koutsouleris, N., Kahn, R. S., Cotter, D. R. & McGuire, P., 1 Jul 2023, In: Schizophrenia Bulletin. 49, 4, p. 893-902 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial
Arad, G., Azriel, O., Pine, D. S., Lazarov, A., Sol, O., Weiser, M., Garber, E., Bloch, M. & Bar-Haim, Y., 1 May 2023, In: American Journal of Psychiatry. 180, 5, p. 357-366 10 p.Research output: Contribution to journal › Article › peer-review
-
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data from the OPTIMISE Study
Levi, L., Bar-Haim, M., Winter-Van Rossum, I., Davidson, M., Leucht, S., Fleischhacker, W. W., Park, J., Davis, J. M., Kahn, R. S. & Weiser, M., 1 Jul 2023, In: Schizophrenia Bulletin. 49, 4, p. 903-913 11 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria
Kane, J. M., Harary, E., Eshet, R., Tohami, O., Weiser, M., Leucht, S., Merenlender-Wagner, A., Sharon, N., Davis, G. L., Suett, M., Franzenburg, K. R. & Correll, C. U., Dec 2023, In: The Lancet Psychiatry. 10, 12, p. 934-943 10 p.Research output: Contribution to journal › Article › peer-review